EXPLANATORY STATEMENT
Issued by authority of the Minister for Health and Ageing
Health Insurance Act 1973
Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1)
Section 4BB of the Health Insurance Act 1973 (the Act) provides that the Minister may determine in writing that a pathology service, or class of pathology services, specified in the determination is a prescribed pathology service.
From 1 November 2010, new arrangements for participating midwives and participating nurse practitioners will enable them to provide Medicare services, refer patients to consultant physicians and specialists, and request pathology and diagnostic imaging services. The proposed Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1) (Determination) is part of the implementation of these new arrangements.
Generally, Medicare eligible pathology services must be provided in an accredited pathology laboratory by an approved pathology practitioner. However, there is an exception for ‘prescribed pathology services’ specified in a determination made under section 4BB of the Act. The purpose of the Determination is to amend the Health Insurance (Prescribed Pathology Services) Determination 2000 to allow participating nurse practitioners to render certain simple basic pathology services for which Medicare benefits are payable.
Details of the proposed Determination are set out in the Attachment.
The Act specifies no conditions that need to be satisfied before the power to make the proposed Determination may be exercised.
The proposed Determination would be a legislative instrument for the purposes of the Legislative Instruments Act 2003.
Consultation regarding implementation of the arrangements for access by patients to midwife and nurse practitioner Medicare services and PBS prescribing occurred via advisory groups established to advise on specific issues and technical aspects. The advisory groups included practitioners from relevant medical and health professions, with experience in midwifery, nursing, general practice, obstetrics, and representatives from registration bodies, state and territory health services, regional and remote health services, Indigenous populations, and consumers. Advice included advice on Medicare and PBS eligibility, collaborative arrangements with medical professionals, authorisation as PBS prescribers, and medicines suitable for PBS prescribing.
ATTACHMENT
Details of the Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1)
Section 1 Name of Determination
This section provides that the name of the Determination is the Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1).
Section 2 Commencement
This section provides that the Determination commences on 1 November 2010.
Section 3 Amendment of Health Insurance (Prescribed Pathology Services) Determination 2000
This section provides that Schedule 1 of the Determination amends the Health Insurance (Prescribed Pathology Services) Determination 2000 (the Principal Determination).
Schedule 1 Amendments
Item [1] – Section 3
This item substitutes a new section 3 in the Principal Determination, which provides that ‘Act’ means the Health Insurance Act 1973.
Item [2] – Section 4
This item removes the term ‘Health Insurance Act 1973’ and replaces with the term ‘Act’ in section 4 of the Principal Determination. This is a minor technical amendment to improve drafting.
Item [3] – After section 4
This item inserts a new section 5 in the Principal Determination. This new section 5 provides that subsection 16A(7A) of the Act applies to a the prescribed pathology services in the range 73801 – 73810 of the Health Insurance Diagnostic Imaging Services Table, where the service is rendered by a participating nurse practitioner.
Where subsection 16A(7A) of the Act applies to a prescribed pathology service rendered by a participating nurse practitioner who is also the patient’s treating practitioner, the prohibition on the payment of Medicare benefit for that pathology service if it is not provided by a approved pathology provider in an accredited pathology laboratory does not apply. This amendment will enable participating nurse practitioners to provide simple basic pathology tests such as pregnancy testing by immunochemical methods, testing for blood in faeces, examining semen for the presence of sperm and microscopy study to determine the presence of fungi in skin, hair or nails as Medicare eligible services.
Overview
The Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1) was enacted to address the gap in the provision of certain simple basic pathology services by participating nurse practitioners, aligning with the introduction of new arrangements that allow such practitioners to provide Medicare services, refer patients to specialist physicians, and request pathology and diagnostic imaging services from 1 November 2010. This amendment to the Health Insurance Act 1973, initiated by the Minister for Health and Ageing, aims to facilitate the inclusion of specific pathology services in the Medicare benefits scheme when rendered by participating nurse practitioners, thereby enhancing patient access to essential healthcare services.
The determination, which amends the Health Insurance (Prescribed Pathology Services) Determination 2000, was developed following consultations with advisory groups comprising healthcare professionals, registration bodies, state and territory health services, regional and remote health services, Indigenous populations, and consumer representatives. The objective was to ensure that the proposed changes appropriately address eligibility for Medicare and the Pharmaceutical Benefits Scheme (PBS), collaborative arrangements with medical professionals, authorisation as PBS prescribers, and the suitability of medicines for PBS prescribing. This legislative instrument, compliant with the Legislative Instruments Act 2003, aims to streamline the provision of pathology services by nurse practitioners, ensuring they can offer basic tests such as pregnancy testing, faecal occult blood testing, semen analysis, and fungal microscopy under the Medicare framework.
Scope and Application
The Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1) is a legislative instrument that amends the Health Insurance (Prescribed Pathology Services) Determination 2000, in turn providing amendments to the Health Insurance Act 1973. This amendment specifically addresses the eligibility of participating nurse practitioners to perform and be reimbursed for certain pathology services under Medicare. Effective from 1 November 2010, this Determination allows participating nurse practitioners to conduct and be compensated for simple basic pathology services that are otherwise restricted to approved pathology providers working in accredited laboratories. These services include tests such as pregnancy testing by immunochemical methods, faecal occult blood tests, semen analysis for sperm presence, and microscopic examinations for fungal presence in skin, hair, or nails. The Amendment Determination introduces a new section that specifies the range of services (73801 – 73810) eligible for these provisions, contingent on the nurse practitioner being the patient’s treating practitioner. This amendment is part of broader changes to enhance access to Medicare services by enabling nurse practitioners and midwives to provide and refer for additional medical services, subject to the conditions outlined in the Determination.
Key Provisions
The Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1) (Determination) amends the Health Insurance (Prescribed Pathology Services) Determination 2000 (Principal Determination) to facilitate new arrangements for participating midwives and nurse practitioners. According to section 1, the name of the Determination is the Health Insurance (Prescribed Pathology Services) Amendment Determination 2010 (No. 1). It commences on 1 November 2010 as stated in section 2. The amendments are outlined in Schedule 1, which modifies the Principal Determination. For instance, section 3 of Schedule 1 substitutes a new definition of 'Act' in section 3 of the Principal Determination, clarifying that it refers to the Health Insurance Act 1973. Section 4 of Schedule 1 corrects a minor technical issue by replacing 'Health Insurance Act 1973' with 'Act' in section 4 of the Principal Determination. Furthermore, section 5 of Schedule 1 introduces a new provision, allowing participating nurse practitioners to render specific pathology services, such as those in the range 73801 – 73810 of the Health Insurance Diagnostic Imaging Services Table, without the requirement of being performed in an accredited pathology laboratory, provided the practitioner is also the patient's treating practitioner.
The Determination imposes obligations on participating nurse practitioners, allowing them to provide certain Medicare-eligible pathology services, provided they meet the criteria specified in the amended Principal Determination. Participating nurse practitioners must ensure they are the treating practitioner of the patient for the services to qualify for Medicare benefits, as outlined in the new section 5. This amendment permits them to perform simple basic pathology tests, such as pregnancy testing by immunochemical methods, testing for blood in faeces, examining semen for the presence of sperm, and microscopy studies to determine the presence of fungi in skin, hair, or nails. The participating nurse practitioners must also comply with any other relevant requirements stipulated in the Health Insurance Act 1973 and associated regulations.
The Act does not specify any particular offences or penalties for breaches of the Determination itself. However, any breach of the Health Insurance Act 1973 or its associated regulations could lead to civil or criminal penalties. For instance, knowingly making a false statement or representation to obtain a benefit under Medicare could result in a civil penalty of up to $22,200 per contravention, or in the case of a corporation, up to $111,000 per contravention. Criminal penalties may also apply, including fines and imprisonment, depending on the nature and seriousness of the offence. The exact penalties would be determined based on the specific provisions of the Act and any relevant case law.